Circio receives waiver of EUR 6.2 million in loans from Business Finland
Oslo, Norway 18 January 2024 – Circio Holding ASA (OSE: CRNA) today announces that Business Finland has approved Circio's application for a waiver in full of three R&D loans totalling EUR 6.2m granted towards the development of ONCOS-102. As a result, Circio's equity will be increased by a corresponding amount.Business Finland is a public agency that provides funding towards R&D activities for companies in Finland. Targovax Oy, a wholly owned Finnish subsidiary of Circio Holding ASA, received three loans from Business Finland for the development and commercialization of ONCOS-102 in 2010,